Clinical Trial Update: Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema [NA]

View source ↗

Summary

A completed clinical trial evaluating Ozurdex (dexamethasone intravitreal implant) for diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Significant Macular Edema
• Cystoid Macular Edema
• Diabetic Macular Edema
• Macular Edema

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Diabetic Macular Edema, Macular Edema, Cystoid | NA | Status: COMPLETED